Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia

被引:0
作者
Keun-Ryung Bae
Hyun-Jung Shim
Deebika Balu
Sang Ryong Kim
Seong-Woon Yu
机构
[1] Daegu Gyeongbuk Institute of Science and Technology (DGIST),Department of Brain Science
[2] Michigan State University,Department of Neurology and Ophthalmology
[3] University of Illinois,Department of Biological Sciences
[4] Kyungpook National University,School of Life Sciences & Biotechnology, Institute of Life Science and Biotechnology, Brain Science and Engineering Institute
来源
Journal of Neuroimmune Pharmacology | 2014年 / 9卷
关键词
Translocator protein 18 kDa; Microglia; Neuroinflammation; NF-κB; Neurodegeneration;
D O I
暂无
中图分类号
学科分类号
摘要
Translocator protein 18 kDa (TSPO) is a mitochondrial outer membrane protein. Although TSPO expression is up-regulated during neuroinflammation, the role of TSPO and its signaling mechanisms in regulation of neuroinflammation remains to be elucidated at the molecular level. Here we demonstrate that TSPO is a negative regulator of neuroinflammation in microglia. Over-expression of TSPO decreased production of pro-inflammatory cytokines upon lipopolysaccharide treatment while TSPO knock-down had the opposite effect. Anti-inflammatory activity of TSPO is also supported by increased expression of alternatively activated M2 stage-related genes. These data suggest that up-regulation of TSPO level during neuroinflammation may be an adaptive response mechanism. We also provide the evidence that the repressive activity of TSPO is at least partially mediated by the attenuation of NF-κB activation. Neurodegenerative diseases are characterized by loss of specific subsets of neurons at the particular anatomical regions of the central nervous system. Cause of neuronal death is still largely unknown, but it is becoming clear that neuroinflammation plays a significant role in the pathophysiology of neurodegenerative diseases. Understanding the mechanisms underlying the inhibitory effects of TSPO on neuroinflammation can contribute to the therapeutic design for neurodegenerative diseases.
引用
收藏
页码:424 / 437
页数:13
相关论文
共 332 条
[1]  
Barron AM(2013)Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease J Neurosci 15 8891-8897
[2]  
Garcia-Segura LM(2007)Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat Rev Neurosci 8 57-69
[3]  
Caruso D(1992)An immortalized cell line expresses properties of activated microglial cells J Neurosci Res 31 616-621.B
[4]  
Jayaraman A(2011)Quantitative, preclinical PET of translocator protein expression in glioma using 18 F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline J Nucl Med 52 107-114
[5]  
Lee JW(2004)In vivo detection of microglial activation in frontotemporal dementia Ann Neurol 56 894-897
[6]  
Melcangi RC(2006)Control of microglial neurotoxicity by the fractalkine receptor Nat Neurosci 9 917-924
[7]  
Pike CJ(2008)Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair Pharmacol Ther 118 1-17
[8]  
Block ML(2011)Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state Glia 59 219-230
[9]  
Zecca L(2002)Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging Eur J Neurosci 15 991-998
[10]  
Hong JS(2003)Parkinson’s disease: review mechanisms and models Neuron 39 889-909